Annora Pharma
FDA Approved Drugs

Annora Pharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Unclassified OTC
  • Total Records 120
  • Latest Approval Date Jul 07, 2026
  • Data Source FDA
  • First Approval Date Jul 01, 2002
All
120
View
Unclassified
10
View
OTC
6
View
RX
104
View
Company Overview

Company

Annora Pharma

Country

India

Website

Visit Website

Email

info@annorapharma.com

Social Profiles

Company Snapshot

Annora Pharma

Sy. No. 261, Annaram Village, Gummadidal Mandal Sangareddy District. Telangana State – 502313

India

www.annorapharma.com/ info@annorapharma.com View on Map
FDA Approved Drug Records ( 120 records )
2022
04 Nov
RX Application: 216464

Drug Name

AMINOCAPROIC ACID

Product Number

1

Dosage Form

-

Strength

0.25GM/ML

Approval Date

2022-11-04

216464 / 1

Active Ingredient

AMINOCAPROIC ACID

Application Number

216464

Product Number

1

Dosage Form

-

Strength

0.25GM/ML

Approval Date

2022-11-04

Regulatory Status

RX

-
Unclassified Application: 214831

Drug Name

BRIVARACETAM

Product Number

2

Dosage Form

-

Strength

25mg

Approval Date

-

214831 / 2

Active Ingredient

BRIVARACETAM

Application Number

214831

Product Number

2

Dosage Form

-

Strength

25mg

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214831

Drug Name

BRIVARACETAM

Product Number

3

Dosage Form

-

Strength

50mg

Approval Date

-

214831 / 3

Active Ingredient

BRIVARACETAM

Application Number

214831

Product Number

3

Dosage Form

-

Strength

50mg

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214831

Drug Name

BRIVARACETAM

Product Number

4

Dosage Form

-

Strength

75mg

Approval Date

-

214831 / 4

Active Ingredient

BRIVARACETAM

Application Number

214831

Product Number

4

Dosage Form

-

Strength

75mg

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214831

Drug Name

BRIVARACETAM

Product Number

5

Dosage Form

-

Strength

100mg

Approval Date

-

214831 / 5

Active Ingredient

BRIVARACETAM

Application Number

214831

Product Number

5

Dosage Form

-

Strength

100mg

Approval Date

-

Regulatory Status

Unclassified

2023
31 May
RX Application: 216800

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-05-31

216800 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

216800

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-05-31

Regulatory Status

RX

2023
31 May
RX Application: 216800

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2023-05-31

216800 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

216800

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2023-05-31

Regulatory Status

RX

2023
31 May
RX Application: 216800

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2023-05-31

216800 / 3

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

216800

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2023-05-31

Regulatory Status

RX

2025
01 Oct
RX Application: 217898

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-10-01

217898 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

217898

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-10-01

Regulatory Status

RX

2025
01 Oct
RX Application: 217898

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-10-01

217898 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

217898

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-10-01

Regulatory Status

RX

2024
29 Apr
RX Application: 217620

Drug Name

COLCHICINE

Product Number

1

Dosage Form

-

Strength

0.6MG

Approval Date

2024-04-29

217620 / 1

Active Ingredient

COLCHICINE

Application Number

217620

Product Number

1

Dosage Form

-

Strength

0.6MG

Approval Date

2024-04-29

Regulatory Status

RX

2025
21 Jan
RX Application: 216168

Drug Name

DARUNAVIR

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2025-01-21

216168 / 1

Active Ingredient

DARUNAVIR

Application Number

216168

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2025-01-21

Regulatory Status

RX

2025
21 Jan
RX Application: 216168

Drug Name

DARUNAVIR

Product Number

2

Dosage Form

-

Strength

800MG

Approval Date

2025-01-21

216168 / 2

Active Ingredient

DARUNAVIR

Application Number

216168

Product Number

2

Dosage Form

-

Strength

800MG

Approval Date

2025-01-21

Regulatory Status

RX

2021
14 May
RX Application: 214341

Drug Name

DEFERASIROX

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2021-05-14

214341 / 1

Active Ingredient

DEFERASIROX

Application Number

214341

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2021-05-14

Regulatory Status

RX

2021
14 May
RX Application: 214341

Drug Name

DEFERASIROX

Product Number

2

Dosage Form

-

Strength

180MG

Approval Date

2021-05-14

214341 / 2

Active Ingredient

DEFERASIROX

Application Number

214341

Product Number

2

Dosage Form

-

Strength

180MG

Approval Date

2021-05-14

Regulatory Status

RX

2021
14 May
RX Application: 214341

Drug Name

DEFERASIROX

Product Number

3

Dosage Form

-

Strength

360MG

Approval Date

2021-05-14

214341 / 3

Active Ingredient

DEFERASIROX

Application Number

214341

Product Number

3

Dosage Form

-

Strength

360MG

Approval Date

2021-05-14

Regulatory Status

RX

2022
22 Sep
RX Application: 216229

Drug Name

DEFERASIROX

Product Number

1

Dosage Form

-

Strength

180MG

Approval Date

2022-09-22

216229 / 1

Active Ingredient

DEFERASIROX

Application Number

216229

Product Number

1

Dosage Form

-

Strength

180MG

Approval Date

2022-09-22

Regulatory Status

RX

2022
22 Sep
RX Application: 216229

Drug Name

DEFERASIROX

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2022-09-22

216229 / 2

Active Ingredient

DEFERASIROX

Application Number

216229

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2022-09-22

Regulatory Status

RX

2023
16 Mar
RX Application: 216229

Drug Name

DEFERASIROX

Product Number

3

Dosage Form

-

Strength

90MG

Approval Date

2023-03-16

216229 / 3

Active Ingredient

DEFERASIROX

Application Number

216229

Product Number

3

Dosage Form

-

Strength

90MG

Approval Date

2023-03-16

Regulatory Status

RX

2026
07 Jul
RX Application: 219670

Drug Name

DESOGESTREL AND ETHINYL ESTRADIOL

Product Number

1

Dosage Form

-

Strength

0.15MG,N/A;0.02MG,0.01MG

Approval Date

2026-07-07

219670 / 1

Active Ingredient

DESOGESTREL; ETHINYL ESTRADIOL

Application Number

219670

Product Number

1

Dosage Form

-

Strength

0.15MG,N/A;0.02MG,0.01MG

Approval Date

2026-07-07

Regulatory Status

RX

2026
18 Mar
RX Application: 219761

Drug Name

DESOGESTREL AND ETHINYL ESTRADIOL

Product Number

1

Dosage Form

-

Strength

0.15MG;0.03MG

Approval Date

2026-03-18

219761 / 1

Active Ingredient

DESOGESTREL; ETHINYL ESTRADIOL

Application Number

219761

Product Number

1

Dosage Form

-

Strength

0.15MG;0.03MG

Approval Date

2026-03-18

Regulatory Status

RX

2023
17 Nov
RX Application: 215049

Drug Name

DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM

Product Number

1

Dosage Form

-

Strength

66%;10%

Approval Date

2023-11-17

215049 / 1

Active Ingredient

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Application Number

215049

Product Number

1

Dosage Form

-

Strength

66%;10%

Approval Date

2023-11-17

Regulatory Status

RX

2022
04 Mar
RX Application: 215375

Drug Name

DICLOFENAC POTASSIUM

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2022-03-04

215375 / 1

Active Ingredient

DICLOFENAC POTASSIUM

Application Number

215375

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2022-03-04

Regulatory Status

RX

2024
07 May
RX Application: 217566

Drug Name

DICYCLOMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2024-05-07

217566 / 1

Active Ingredient

DICYCLOMINE HYDROCHLORIDE

Application Number

217566

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2024-05-07

Regulatory Status

RX

2024
01 Jul
RX Application: 218018

Drug Name

DICYCLOMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2024-07-01

218018 / 1

Active Ingredient

DICYCLOMINE HYDROCHLORIDE

Application Number

218018

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2024-07-01

Regulatory Status

RX

2026
17 Jun
RX Application: 219470

Drug Name

DIPHENHYDRAMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

12.5MG/5ML

Approval Date

2026-06-17

219470 / 1

Active Ingredient

DIPHENHYDRAMINE HYDROCHLORIDE

Application Number

219470

Product Number

1

Dosage Form

-

Strength

12.5MG/5ML

Approval Date

2026-06-17

Regulatory Status

RX

2023
26 Sep
RX Application: 215527

Drug Name

DIVALPROEX SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 250MG VALPROIC ACID

Approval Date

2023-09-26

215527 / 1

Active Ingredient

DIVALPROEX SODIUM

Application Number

215527

Product Number

1

Dosage Form

-

Strength

EQ 250MG VALPROIC ACID

Approval Date

2023-09-26

Regulatory Status

RX

2023
26 Sep
RX Application: 215527

Drug Name

DIVALPROEX SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 500MG VALPROIC ACID

Approval Date

2023-09-26

215527 / 2

Active Ingredient

DIVALPROEX SODIUM

Application Number

215527

Product Number

2

Dosage Form

-

Strength

EQ 500MG VALPROIC ACID

Approval Date

2023-09-26

Regulatory Status

RX

2025
07 Jul
RX Application: 219143

Drug Name

ELETRIPTAN HYDROBROMIDE

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2025-07-07

219143 / 1

Active Ingredient

ELETRIPTAN HYDROBROMIDE

Application Number

219143

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2025-07-07

Regulatory Status

RX

2025
07 Jul
RX Application: 219143

Drug Name

ELETRIPTAN HYDROBROMIDE

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2025-07-07

219143 / 2

Active Ingredient

ELETRIPTAN HYDROBROMIDE

Application Number

219143

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2025-07-07

Regulatory Status

RX

2024
18 Apr
RX Application: 216620

Drug Name

ELTROMBOPAG OLAMINE

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG ACID/PACKET

Approval Date

2024-04-18

216620 / 1

Active Ingredient

ELTROMBOPAG OLAMINE

Application Number

216620

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG ACID/PACKET

Approval Date

2024-04-18

Regulatory Status

RX

2024
18 Apr
RX Application: 216620

Drug Name

ELTROMBOPAG OLAMINE

Product Number

2

Dosage Form

-

Strength

EQ 25MG ACID/PACKET

Approval Date

2024-04-18

216620 / 2

Active Ingredient

ELTROMBOPAG OLAMINE

Application Number

216620

Product Number

2

Dosage Form

-

Strength

EQ 25MG ACID/PACKET

Approval Date

2024-04-18

Regulatory Status

RX

-
Unclassified Application: 212365

Drug Name

EMPAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

212365 / 1

Active Ingredient

EMPAGLIFLOZIN

Application Number

212365

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212365

Drug Name

EMPAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

212365 / 2

Active Ingredient

EMPAGLIFLOZIN

Application Number

212365

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212364

Drug Name

EMPAGLIFLOZIN; LINAGLIPTIN

Product Number

1

Dosage Form

-

Strength

10MG; 5MG

Approval Date

-

212364 / 1

Active Ingredient

EMPAGLIFLOZIN;LINAGLIPTIN

Application Number

212364

Product Number

1

Dosage Form

-

Strength

10MG; 5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 212364

Drug Name

EMPAGLIFLOZIN; LINAGLIPTIN

Product Number

2

Dosage Form

-

Strength

25MG; 5MG

Approval Date

-

212364 / 2

Active Ingredient

EMPAGLIFLOZIN;LINAGLIPTIN

Application Number

212364

Product Number

2

Dosage Form

-

Strength

25MG; 5MG

Approval Date

-

Regulatory Status

Unclassified

2022
24 Feb
RX Application: 214467

Drug Name

ENALAPRIL MALEATE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2022-02-24

214467 / 1

Active Ingredient

ENALAPRIL MALEATE

Application Number

214467

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2022-02-24

Regulatory Status

RX

2023
02 Jun
RX Application: 213812

Drug Name

EPLERENONE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2023-06-02

213812 / 1

Active Ingredient

EPLERENONE

Application Number

213812

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2023-06-02

Regulatory Status

RX

2023
02 Jun
RX Application: 213812

Drug Name

EPLERENONE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2023-06-02

213812 / 2

Active Ingredient

EPLERENONE

Application Number

213812

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2023-06-02

Regulatory Status

RX

2021
08 Nov
OTC Application: 215766

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2021-11-08

215766 / 1

Active Ingredient

FAMOTIDINE

Application Number

215766

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2021-11-08

Regulatory Status

OTC

2021
08 Nov
OTC Application: 215766

Drug Name

FAMOTIDINE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2021-11-08

215766 / 2

Active Ingredient

FAMOTIDINE

Application Number

215766

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2021-11-08

Regulatory Status

OTC

2021
04 Nov
RX Application: 215767

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2021-11-04

215767 / 1

Active Ingredient

FAMOTIDINE

Application Number

215767

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2021-11-04

Regulatory Status

RX

2021
04 Nov
RX Application: 215767

Drug Name

FAMOTIDINE

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2021-11-04

215767 / 2

Active Ingredient

FAMOTIDINE

Application Number

215767

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2021-11-04

Regulatory Status

RX

2023
17 Aug
RX Application: 217330

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

40MG/5ML

Approval Date

2023-08-17

217330 / 1

Active Ingredient

FAMOTIDINE

Application Number

217330

Product Number

1

Dosage Form

-

Strength

40MG/5ML

Approval Date

2023-08-17

Regulatory Status

RX

2025
30 Jul
RX Application: 217024

Drug Name

FLUVOXAMINE MALEATE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2025-07-30

217024 / 1

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

217024

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2025-07-30

Regulatory Status

RX

2025
30 Jul
RX Application: 217024

Drug Name

FLUVOXAMINE MALEATE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2025-07-30

217024 / 2

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

217024

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2025-07-30

Regulatory Status

RX

2026
17 Jun
RX Application: 217329

Drug Name

FOSTAMATINIB DISODIUM

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-06-17

217329 / 1

Active Ingredient

FOSTAMATINIB DISODIUM

Application Number

217329

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-06-17

Regulatory Status

RX

2026
17 Jun
RX Application: 217329

Drug Name

FOSTAMATINIB DISODIUM

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2026-06-17

217329 / 2

Active Ingredient

FOSTAMATINIB DISODIUM

Application Number

217329

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2026-06-17

Regulatory Status

RX

2024
17 Jan
RX Application: 217682

Drug Name

GABAPENTIN

Product Number

1

Dosage Form

-

Strength

250MG/5ML

Approval Date

2024-01-17

217682 / 1

Active Ingredient

GABAPENTIN

Application Number

217682

Product Number

1

Dosage Form

-

Strength

250MG/5ML

Approval Date

2024-01-17

Regulatory Status

RX

2024
26 Feb
RX Application: 218075

Drug Name

GABAPENTIN

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2024-02-26

218075 / 1

Active Ingredient

GABAPENTIN

Application Number

218075

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2024-02-26

Regulatory Status

RX

2024
26 Feb
RX Application: 218075

Drug Name

GABAPENTIN

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2024-02-26

218075 / 2

Active Ingredient

GABAPENTIN

Application Number

218075

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2024-02-26

Regulatory Status

RX

-
Unclassified Application: 215139

Drug Name

GLYCEROL PHENYLBUTYRATE

Product Number

1

Dosage Form

-

Strength

1.1G/ML

Approval Date

-

215139 / 1

Active Ingredient

GLYCEROL PHENYLBUTYRATE

Application Number

215139

Product Number

1

Dosage Form

-

Strength

1.1G/ML

Approval Date

-

Regulatory Status

Unclassified

2022
05 Jul
RX Application: 213698

Drug Name

GLYCOPYRROLATE

Product Number

1

Dosage Form

-

Strength

1MG/5ML

Approval Date

2022-07-05

213698 / 1

Active Ingredient

GLYCOPYRROLATE

Application Number

213698

Product Number

1

Dosage Form

-

Strength

1MG/5ML

Approval Date

2022-07-05

Regulatory Status

RX

2018
23 Nov
OTC Application: 210602

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2018-11-23

210602 / 1

Active Ingredient

IBUPROFEN

Application Number

210602

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2018-11-23

Regulatory Status

OTC

2025
03 Jul
RX Application: 216905

Drug Name

INDOMETHACIN

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2025-07-03

216905 / 1

Active Ingredient

INDOMETHACIN

Application Number

216905

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2025-07-03

Regulatory Status

RX

2020
01 Sep
RX Application: 212239

Drug Name

ITRACONAZOLE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2020-09-01

212239 / 1

Active Ingredient

ITRACONAZOLE

Application Number

212239

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2020-09-01

Regulatory Status

RX

2022
05 Oct
RX Application: 213366

Drug Name

IVABRADINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2022-10-05

213366 / 1

Active Ingredient

IVABRADINE HYDROCHLORIDE

Application Number

213366

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2022-10-05

Regulatory Status

RX

2022
05 Oct
RX Application: 213366

Drug Name

IVABRADINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 7.5MG BASE

Approval Date

2022-10-05

213366 / 2

Active Ingredient

IVABRADINE HYDROCHLORIDE

Application Number

213366

Product Number

2

Dosage Form

-

Strength

EQ 7.5MG BASE

Approval Date

2022-10-05

Regulatory Status

RX

2026
26 May
RX Application: 219722

Drug Name

L-GLUTAMINE

Product Number

1

Dosage Form

-

Strength

5GM/PACKET

Approval Date

2026-05-26

219722 / 1

Active Ingredient

L-GLUTAMINE

Application Number

219722

Product Number

1

Dosage Form

-

Strength

5GM/PACKET

Approval Date

2026-05-26

Regulatory Status

RX

2025
30 Sep
OTC Application: 219102

Drug Name

LEVONORGESTREL

Product Number

1

Dosage Form

-

Strength

1.5MG

Approval Date

2025-09-30

219102 / 1

Active Ingredient

LEVONORGESTREL

Application Number

219102

Product Number

1

Dosage Form

-

Strength

1.5MG

Approval Date

2025-09-30

Regulatory Status

OTC

2002
01 Jul
RX Application: 75903

Drug Name

LISINOPRIL

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2002-07-01

75903 / 1

Active Ingredient

LISINOPRIL

Application Number

75903

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 75903

Drug Name

LISINOPRIL

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2002-07-01

75903 / 2

Active Ingredient

LISINOPRIL

Application Number

75903

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 75903

Drug Name

LISINOPRIL

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2002-07-01

75903 / 3

Active Ingredient

LISINOPRIL

Application Number

75903

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 75903

Drug Name

LISINOPRIL

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2002-07-01

75903 / 4

Active Ingredient

LISINOPRIL

Application Number

75903

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 75903

Drug Name

LISINOPRIL

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2002-07-01

75903 / 5

Active Ingredient

LISINOPRIL

Application Number

75903

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 75903

Drug Name

LISINOPRIL

Product Number

6

Dosage Form

-

Strength

40MG

Approval Date

2002-07-01

75903 / 6

Active Ingredient

LISINOPRIL

Application Number

75903

Product Number

6

Dosage Form

-

Strength

40MG

Approval Date

2002-07-01

Regulatory Status

RX

-
Unclassified Application: 218419

Drug Name

LISINOPRIL

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

-

218419 / 1

Active Ingredient

LISINOPRIL

Application Number

218419

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

-

Regulatory Status

Unclassified

2024
21 Aug
RX Application: 218174

Drug Name

LURASIDONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2024-08-21

218174 / 1

Active Ingredient

LURASIDONE HYDROCHLORIDE

Application Number

218174

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

2024-08-21

Regulatory Status

RX

2024
21 Aug
RX Application: 218174

Drug Name

LURASIDONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2024-08-21

218174 / 2

Active Ingredient

LURASIDONE HYDROCHLORIDE

Application Number

218174

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

2024-08-21

Regulatory Status

RX

2024
21 Aug
RX Application: 218174

Drug Name

LURASIDONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

60MG

Approval Date

2024-08-21

218174 / 3

Active Ingredient

LURASIDONE HYDROCHLORIDE

Application Number

218174

Product Number

3

Dosage Form

-

Strength

60MG

Approval Date

2024-08-21

Regulatory Status

RX

2024
21 Aug
RX Application: 218174

Drug Name

LURASIDONE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

80MG

Approval Date

2024-08-21

218174 / 4

Active Ingredient

LURASIDONE HYDROCHLORIDE

Application Number

218174

Product Number

4

Dosage Form

-

Strength

80MG

Approval Date

2024-08-21

Regulatory Status

RX

2024
21 Aug
RX Application: 218174

Drug Name

LURASIDONE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

120MG

Approval Date

2024-08-21

218174 / 5

Active Ingredient

LURASIDONE HYDROCHLORIDE

Application Number

218174

Product Number

5

Dosage Form

-

Strength

120MG

Approval Date

2024-08-21

Regulatory Status

RX

2020
19 Mar
RX Application: 213377

Drug Name

MESALAMINE

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2020-03-19

213377 / 1

Active Ingredient

MESALAMINE

Application Number

213377

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2020-03-19

Regulatory Status

RX

2024
05 Feb
RX Application: 216334

Drug Name

MESALAMINE

Product Number

1

Dosage Form

-

Strength

1.2GM

Approval Date

2024-02-05

216334 / 1

Active Ingredient

MESALAMINE

Application Number

216334

Product Number

1

Dosage Form

-

Strength

1.2GM

Approval Date

2024-02-05

Regulatory Status

RX

2025
13 Aug
RX Application: 219864

Drug Name

MESALAMINE

Product Number

1

Dosage Form

-

Strength

375MG

Approval Date

2025-08-13

219864 / 1

Active Ingredient

MESALAMINE

Application Number

219864

Product Number

1

Dosage Form

-

Strength

375MG

Approval Date

2025-08-13

Regulatory Status

RX

2025
13 Mar
RX Application: 215008

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG/5ML

Approval Date

2025-03-13

215008 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

215008

Product Number

1

Dosage Form

-

Strength

500MG/5ML

Approval Date

2025-03-13

Regulatory Status

RX

2022
09 Nov
RX Application: 216463

Drug Name

MEXILETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2022-11-09

216463 / 1

Active Ingredient

MEXILETINE HYDROCHLORIDE

Application Number

216463

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2022-11-09

Regulatory Status

RX

2022
09 Nov
RX Application: 216463

Drug Name

MEXILETINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2022-11-09

216463 / 2

Active Ingredient

MEXILETINE HYDROCHLORIDE

Application Number

216463

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2022-11-09

Regulatory Status

RX

2022
09 Nov
RX Application: 216463

Drug Name

MEXILETINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

2022-11-09

216463 / 3

Active Ingredient

MEXILETINE HYDROCHLORIDE

Application Number

216463

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

2022-11-09

Regulatory Status

RX

2025
02 Oct
RX Application: 219721

Drug Name

MIRTAZAPINE

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2025-10-02

219721 / 1

Active Ingredient

MIRTAZAPINE

Application Number

219721

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2025-10-02

Regulatory Status

RX

2025
02 Oct
RX Application: 219721

Drug Name

MIRTAZAPINE

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-10-02

219721 / 2

Active Ingredient

MIRTAZAPINE

Application Number

219721

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-10-02

Regulatory Status

RX

2025
02 Oct
RX Application: 219721

Drug Name

MIRTAZAPINE

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2025-10-02

219721 / 3

Active Ingredient

MIRTAZAPINE

Application Number

219721

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2025-10-02

Regulatory Status

RX

2025
02 Oct
RX Application: 219721

Drug Name

MIRTAZAPINE

Product Number

4

Dosage Form

-

Strength

45MG

Approval Date

2025-10-02

219721 / 4

Active Ingredient

MIRTAZAPINE

Application Number

219721

Product Number

4

Dosage Form

-

Strength

45MG

Approval Date

2025-10-02

Regulatory Status

RX

2011
12 Jan
RX Application: 90445

Drug Name

NABUMETONE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2011-01-12

90445 / 1

Active Ingredient

NABUMETONE

Application Number

90445

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2011-01-12

Regulatory Status

RX

2011
12 Jan
RX Application: 90445

Drug Name

NABUMETONE

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2011-01-12

90445 / 2

Active Ingredient

NABUMETONE

Application Number

90445

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2011-01-12

Regulatory Status

RX

2024
09 Jul
RX Application: 216937

Drug Name

NIMODIPINE

Product Number

1

Dosage Form

-

Strength

3MG/ML

Approval Date

2024-07-09

216937 / 1

Active Ingredient

NIMODIPINE

Application Number

216937

Product Number

1

Dosage Form

-

Strength

3MG/ML

Approval Date

2024-07-09

Regulatory Status

RX

2025
15 Apr
RX Application: 218701

Drug Name

NITAZOXANIDE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2025-04-15

218701 / 1

Active Ingredient

NITAZOXANIDE

Application Number

218701

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2025-04-15

Regulatory Status

RX

2025
02 Jul
RX Application: 219495

Drug Name

NITROFURANTOIN

Product Number

1

Dosage Form

-

Strength

25MG/5ML

Approval Date

2025-07-02

219495 / 1

Active Ingredient

NITROFURANTOIN

Application Number

219495

Product Number

1

Dosage Form

-

Strength

25MG/5ML

Approval Date

2025-07-02

Regulatory Status

RX

2022
11 Jan
RX Application: 215939

Drug Name

OXCARBAZEPINE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2022-01-11

215939 / 1

Active Ingredient

OXCARBAZEPINE

Application Number

215939

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2022-01-11

Regulatory Status

RX

2022
11 Jan
RX Application: 215939

Drug Name

OXCARBAZEPINE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2022-01-11

215939 / 2

Active Ingredient

OXCARBAZEPINE

Application Number

215939

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2022-01-11

Regulatory Status

RX

2022
11 Jan
RX Application: 215939

Drug Name

OXCARBAZEPINE

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2022-01-11

215939 / 3

Active Ingredient

OXCARBAZEPINE

Application Number

215939

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

2022-01-11

Regulatory Status

RX

2023
27 Oct
RX Application: 216139

Drug Name

PANTOPRAZOLE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-10-27

216139 / 1

Active Ingredient

PANTOPRAZOLE SODIUM

Application Number

216139

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2023-10-27

Regulatory Status

RX

2026
05 Mar
RX Application: 219954

Drug Name

PAROXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/5ML

Approval Date

2026-03-05

219954 / 1

Active Ingredient

PAROXETINE HYDROCHLORIDE

Application Number

219954

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/5ML

Approval Date

2026-03-05

Regulatory Status

RX

2014
07 Apr
RX Application: 204133

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2014-04-07

204133 / 1

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

204133

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2014-04-07

Regulatory Status

RX

2014
07 Apr
RX Application: 204133

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2014-04-07

204133 / 2

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

204133

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2014-04-07

Regulatory Status

RX

2014
07 Apr
RX Application: 204133

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2014-04-07

204133 / 3

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

204133

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2014-04-07

Regulatory Status

RX

2021
14 Apr
OTC Application: 214990

Drug Name

POLYETHYLENE GLYCOL 3350

Product Number

1

Dosage Form

-

Strength

17GM/SCOOPFUL

Approval Date

2021-04-14

214990 / 1

Active Ingredient

POLYETHYLENE GLYCOL 3350

Application Number

214990

Product Number

1

Dosage Form

-

Strength

17GM/SCOOPFUL

Approval Date

2021-04-14

Regulatory Status

OTC

2021
14 Apr
OTC Application: 214990

Drug Name

POLYETHYLENE GLYCOL 3350

Product Number

2

Dosage Form

-

Strength

17GM/PACKET

Approval Date

2021-04-14

214990 / 2

Active Ingredient

POLYETHYLENE GLYCOL 3350

Application Number

214990

Product Number

2

Dosage Form

-

Strength

17GM/PACKET

Approval Date

2021-04-14

Regulatory Status

OTC

2022
02 Nov
RX Application: 216446

Drug Name

PROMETHAZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2022-11-02

216446 / 1

Active Ingredient

PROMETHAZINE HYDROCHLORIDE

Application Number

216446

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2022-11-02

Regulatory Status

RX

2022
02 Nov
RX Application: 216446

Drug Name

PROMETHAZINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2022-11-02

216446 / 2

Active Ingredient

PROMETHAZINE HYDROCHLORIDE

Application Number

216446

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2022-11-02

Regulatory Status

RX

2025
24 Jun
RX Application: 219160

Drug Name

PRUCALOPRIDE SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-06-24

219160 / 1

Active Ingredient

PRUCALOPRIDE SUCCINATE

Application Number

219160

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-06-24

Regulatory Status

RX

2025
24 Jun
RX Application: 219160

Drug Name

PRUCALOPRIDE SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-06-24

219160 / 2

Active Ingredient

PRUCALOPRIDE SUCCINATE

Application Number

219160

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-06-24

Regulatory Status

RX

2022
18 Aug
RX Application: 215420

Drug Name

SAPROPTERIN DIHYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG/PACKET

Approval Date

2022-08-18

215420 / 1

Active Ingredient

SAPROPTERIN DIHYDROCHLORIDE

Application Number

215420

Product Number

1

Dosage Form

-

Strength

100MG/PACKET

Approval Date

2022-08-18

Regulatory Status

RX

2022
18 Aug
RX Application: 215420

Drug Name

SAPROPTERIN DIHYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2022-08-18

215420 / 2

Active Ingredient

SAPROPTERIN DIHYDROCHLORIDE

Application Number

215420

Product Number

2

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2022-08-18

Regulatory Status

RX

2022
23 Aug
RX Application: 215534

Drug Name

SAPROPTERIN DIHYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2022-08-23

215534 / 1

Active Ingredient

SAPROPTERIN DIHYDROCHLORIDE

Application Number

215534

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2022-08-23

Regulatory Status

RX

2024
18 Oct
RX Application: 212903

Drug Name

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

Product Number

1

Dosage Form

-

Strength

1.6GM/BOT;3.13GM/BOT;17.5GM/BOT

Approval Date

2024-10-18

212903 / 1

Active Ingredient

MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Application Number

212903

Product Number

1

Dosage Form

-

Strength

1.6GM/BOT;3.13GM/BOT;17.5GM/BOT

Approval Date

2024-10-18

Regulatory Status

RX

2022
15 Jun
RX Application: 215761

Drug Name

SOLIFENACIN SUCCINATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2022-06-15

215761 / 1

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

215761

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2022-06-15

Regulatory Status

RX

2022
15 Jun
RX Application: 215761

Drug Name

SOLIFENACIN SUCCINATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2022-06-15

215761 / 2

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

215761

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2022-06-15

Regulatory Status

RX

2025
25 Jul
RX Application: 217761

Drug Name

SPIRONOLACTONE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2025-07-25

217761 / 1

Active Ingredient

SPIRONOLACTONE

Application Number

217761

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2025-07-25

Regulatory Status

RX

2025
25 Jul
RX Application: 217761

Drug Name

SPIRONOLACTONE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2025-07-25

217761 / 2

Active Ingredient

SPIRONOLACTONE

Application Number

217761

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2025-07-25

Regulatory Status

RX

2025
25 Jul
RX Application: 217761

Drug Name

SPIRONOLACTONE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2025-07-25

217761 / 3

Active Ingredient

SPIRONOLACTONE

Application Number

217761

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2025-07-25

Regulatory Status

RX

2023
08 Sep
RX Application: 217422

Drug Name

THEOPHYLLINE

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2023-09-08

217422 / 1

Active Ingredient

THEOPHYLLINE

Application Number

217422

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2023-09-08

Regulatory Status

RX

2023
08 Sep
RX Application: 217422

Drug Name

THEOPHYLLINE

Product Number

2

Dosage Form

-

Strength

450MG

Approval Date

2023-09-08

217422 / 2

Active Ingredient

THEOPHYLLINE

Application Number

217422

Product Number

2

Dosage Form

-

Strength

450MG

Approval Date

2023-09-08

Regulatory Status

RX

2019
08 Jul
RX Application: 212277

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2019-07-08

212277 / 1

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

212277

Product Number

1

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2019-07-08

Regulatory Status

RX

2019
08 Jul
RX Application: 212277

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2019-07-08

212277 / 2

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

212277

Product Number

2

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2019-07-08

Regulatory Status

RX

2019
08 Jul
RX Application: 212277

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2019-07-08

212277 / 3

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

212277

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2019-07-08

Regulatory Status

RX

2021
26 Jan
RX Application: 213519

Drug Name

VIGABATRIN

Product Number

1

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2021-01-26

213519 / 1

Active Ingredient

VIGABATRIN

Application Number

213519

Product Number

1

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2021-01-26

Regulatory Status

RX

2020
10 Sep
RX Application: 212475

Drug Name

ZAFIRLUKAST

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2020-09-10

212475 / 1

Active Ingredient

ZAFIRLUKAST

Application Number

212475

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2020-09-10

Regulatory Status

RX

2020
10 Sep
RX Application: 212475

Drug Name

ZAFIRLUKAST

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2020-09-10

212475 / 2

Active Ingredient

ZAFIRLUKAST

Application Number

212475

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2020-09-10

Regulatory Status

RX

2022
11 Oct
RX Application: 215742

Drug Name

ZILEUTON

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2022-10-11

215742 / 1

Active Ingredient

ZILEUTON

Application Number

215742

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2022-10-11

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    120 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
120 total
  • RX
  • Unclassified
  • OTC
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMINOCAPROIC ACID

Application Number

216464

Product Number

1

Active Ingredient

AMINOCAPROIC ACID

Dosage Form

-

Strength

0.25GM/ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit